“…In a number of experimental systems in vitro, the activity of lymphoid cells was shown to be affected by treatment with histamine or histamine H2-receptor agonists/antagonists. These systems include antigenor mitogen-induced lymphtocyte proliferation (Strannegard & Strannegard, 1977;Wang & Zweiman, 1978;Brostoff etal., 1980;Hebert et al, 1980;Ogden & Hill, 1980;Suzuki & Huchet, 1981), lymphocyte-mediated cytotoxicity in different systems (Plaut et al, 1975;Schwartz et al, 1980;1981), production of migration inhibition factor (Rocklin, 1976), and antibody production (Lima & Rocklin, 1981;Szewczuk, et al, 1981). Strannegard & Strannegard (1977) also showed that lymphocytes from atopic individuals are more sensitive to inhibition of PHA-induced thymidine incorporation by histamine than cells from normal individuals.…”